Ignite Creation Date:
2024-05-06 @ 6:27 PM
Last Modification Date:
2024-10-26 @ 2:48 PM
Study NCT ID:
NCT05664139
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-02-08
First Post:
2022-12-08
Brief Title:
Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma
Sponsor:
Fujian Cancer Hospital
Organization:
Fujian Cancer Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12
Completion Date Type:
ESTIMATED
First Submit Date:
2022-12-08
First Submit QC Date:
December 16 2022
Study First Post Date:
2022-12-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-06
Last Update Post Date:
2023-02-08
Last Update Post Date Type:
ACTUAL